Cash Flow Gaush Meditech Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
124.00
168.00
273.00
-319.00
-166.00
167.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-10.00
-112.00
-36.00
-6.00
-95.00
-4.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
139.00
81.00
231.00
229.00
109.00
154.00
Cash Flow from Investing Activities
21.00
19.00
-192.00
-165.00
96.00
-1,124.00
Cash Flow from Financing Activities
-207.00
-296.00
-160.00
50.00
184.00
964.00
Net Cash Inflow / Outflow
-2.00
-217.00
-115.00
126.00
371.00
-20.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
44.00
-22.00
6.00
12.00
-18.00
-15.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Gaush Meditech Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
124.377478247954
377.359516408042
-253.00
-67.04%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-10.9667003247472
-180.603060844325
170.00
93.93%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
139.039149696753
232.010148093201
-93.00
-40.07%
Cash Flow from Investing Activities
21.227375935154
-240.31293061065
261.00
108.83%
Cash Flow from Financing Activities
-207.446545828453
-227.285747900175
20.00
8.73%
Net Cash Inflow / Outflow
-2.58116562231985
-232.992449123435
230.00
98.89%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
44.5988545742265
2.59608129418804
42.00
1617.93%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 70.63% vs -64.76% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
139.04
81.48
70.63%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
